Evidence map›Paper›PMID 20537810›Full record

Trial reportDrug and alcohol dependence2010

A randomized, controlled trial of NRT-aided gradual vs. abrupt cessation in smokers actively trying to quit.

John R Hughes, Laura J Solomon, Amy E Livingston, Peter W Callas, Erica N Peters

Registry-linked trialAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00297492 (Gradual vs. Abrupt Cessation Treatment for Smoking), which is not on this map. Cited by 37 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00297492 phase2completednot on this map

Gradual vs. Abrupt Cessation Treatment for Smoking

TypeinterventionalSponsorUniversity of VermontRan2006 to 2008Enrolled750ConditionsSmoking CessationArmsReduction Phone Counseling, Abrupt Phone Counseling, Minimal Abrupt Phone Counseling, Pre-Quit Nicotine Lozenges, Post-Quit Nicotine Lozenges
3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Smoking reduction interventions for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  3. Telephone counselling for smoking cessation.The Cochrane database of systematic reviews · 2019
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Efficacy of a Texting Program to Promote Cessation Among Pregnant Smokers: A Randomized Control Trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Trial
  7. Trial
  8. Trial
  9. Trial
  10. Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2015
    Trial
  11. A mechanistic test of nicotine replacement therapy sampling for smoking cessation induction.Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors · 2015
    Trial
  12. Trial
  13. Trial
  14. A randomized placebo-controlled trial of varenicline for smoking cessation allowing flexible quit dates.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2012
    Trial
  15. Is delaying a quit attempt associated with less success?Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2011
    Trial
  16. Efficacy of varenicline to prompt quit attempts in smokers not currently trying to quit: a randomized placebo-controlled trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2011
    Trial
  17. Trial
  18. Trial
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

John R HughesUniversity of Vermont, Burlington, VT, USA. john.hughes@uvm.edu
Laura J Solomon
Amy E Livingston
Peter W Callas
Erica N Peters

Funding

TRAINING IN BEHAV. PHARMACOLOGY OF HUMAN DRUG DEPENDENCET32DA007242 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HEIL, SARAH H, HIGGINS, STEPHEN T · 1990 to 2025
$8.2M
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPESR01DA007242 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PAN, YING-XIAN · 1991 to 2022
$6.0M
REDUCED SMOKING TO PROMPT SMOKING CESSATIONR01DA011557 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HUGHES, JOHN R · 1998 to 2007
$2.7M
PHARMACOLOGY OF OPIOID RECEPTOR SUBTYPESR37DA007242 · NIDA · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI PASTERNAK, GAVRIL W · 1996 to 2004
$1.5M
Research on Tobacco and Marijuana Cessation &ReductionK05DA000490 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HUGHES, JOHN R · 2000 to 2009
$1.4M
Internal Barriers to Seeking Smoking Cessation TreatmentR01DA017825 · NIDA · UNIVERSITY OF VERMONT &ST AGRIC COLLEGE · PI HUGHES, JOHN R · 2005 to 2007
$1.2M
NIDA NIH HHS DA-00490NIDA NIH HHS DA-017825NIDA NIH HHS DA-07242NIDA NIH HHS K05 DA000490NIDA NIH HHS R01 DA011557NIDA NIH HHS T32 DA007242
6 · The paper itself

Abstract

Most smoking cessation programs advise abrupt rather than gradual cessation. We conducted a randomized, controlled trial of gradual cessation (n=297) vs. abrupt cessation (n=299) vs. minimal treatment (n=150) among smokers who wanted to quit now and preferred to quit gradually. Participants were recruited via newspaper and radio advertisements. The gradual and abrupt conditions received five phone calls (total=90 min) and the minimal treatment condition received two calls (25 min total). The gradual condition received nicotine lozenge (via mail) to reduce smoking prior to their quit date. After the quit day, all participants received lozenge. The primary outcome was prolonged abstinence from 2 weeks post-quit day through 6 months. Prior to the quit day, the gradual condition decreased cigarettes/day by 54%, whereas the other two conditions decreased by 1% and 5%. Prolonged abstinence rates (CO<10 ppm) did not differ among gradual, abrupt and minimal treatment conditions (4%, 7% and 5%), nor did 7-day point prevalence rates (7%, 11% and 11%). Fewer smokers in the gradual condition (48%) made a quit attempt than in the abrupt (64%) or minimal (60%) conditions (p<.001). In the gradual condition, every week delay to the quit date increased the probability of lapsing by 19% (p<.001). We conclude that among smokers who want to stop gradually in the near future, gradual cessation with nicotine pre-treatment does not produce higher quit rates than abrupt cessation. One liability of gradual reduction may be that it allows smokers to delay their quit date.

Indexed as

AdultFemaleHumansMaleMiddle AgedNicotineNicotinic AgonistsPatient ComplianceSelf EfficacySmoking CessationTime FactorsTobacco Use DisorderTreatment OutcomeNicotineNicotinic Agonists

Identifiers

PMID20537810
PMCPMC2930079

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.